Drug shortages have plagued health care for decades. Even prior to COVID-19, hospitals incurred more than $400 million in labor costs and alternative treatment options due to national generic drug shortages, especially for those administered via injection. And research shows shortages lead to things like delaying critical procedures, rationing doses...
The entire story is available at Clemson's website . Drug shortages have plagued the health care system for decades. Even prior to COVID-19, hospitals incurred more than $400 million in labor costs and alternative treatment options due to national generic drug shortages, especially for those administered via injection. More important...
Nephron Pharmaceuticals Corporation is partnering with Clemson University to create a robotic solution for syringe-filling automation to enhance sterile manufacturing in the pharmaceutical production process and keep up with growing hospital demands. “We are excited about our new partnership with Clemson, and we cannot wait to get started,” said Nephron...
